CBD may be everywhere—from creams and capsules to dog treats—but that doesn’t mean it’s fully approved by the U.S. Food and Drug Administration (FDA). In fact, most CBD products are still unregulated, leaving consumers and business owners in a gray area.
Here’s what you need to know in 2025 to stay compliant, stay safe, and understand where federal regulation is heading.
🏛️ What’s the FDA’s Current Stance on CBD?
The FDA recognizes the potential of CBD but maintains a cautious stance. Currently:
| Product Type | FDA-Approved to Contain CBD? |
|---|---|
| Prescription Drugs | ✅ Yes (e.g., Epidiolex) |
| Dietary Supplements | ❌ No |
| Food & Beverages | ❌ No |
| Cosmetics (Topicals) | ⚠️ Yes, if no medical claims |
| Animal Products (Pets) | ❌ No |
🧠 Why the Restrictions?
- Lack of long-term safety data
- No approved dosing guidelines
- CBD is already classified as a drug (Epidiolex), making it illegal to add to foods or supplements without explicit approval
📜 Enforcement Trends (2022–2025)
The FDA has issued over 80 warning letters since 2019 to companies that:
- Claim CBD treats diseases (e.g., cancer, Alzheimer’s)
- Market CBD as a dietary supplement
- Include unverified potency claims
Here’s a chart showing the number of FDA enforcement actions per year:
| Year | Warning Letters Sent | Top Violations |
|---|---|---|
| 2020 | 18 | Disease claims, mislabeled dosage |
| 2021 | 22 | Supplement claims |
| 2022 | 15 | Inaccurate COAs, pet claims |
| 2023 | 11 | Topical medical claims |
| 2024 | 9 | Email & website claims |
🧴 What’s Allowed in 2025?
✅ You Can:
- Sell CBD topicals (lotions, creams, balms) as cosmetics
- Sell CBD if you make no health or disease claims
- Provide third-party lab results (COAs) for product transparency
- Use QR codes to link to test results
❌ You Cannot:
- Claim CBD treats pain, anxiety, cancer, etc. (without FDA approval)
- Market it as a supplement or additive to food
- Add CBD to pet foods or animal treats
- Skip lab testing—especially in interstate commerce
🧬 What About Epidiolex?
Epidiolex remains the only FDA-approved CBD product in the U.S. It’s a prescription drug used to treat rare forms of epilepsy and requires medical oversight.
Its approval created a regulatory hurdle: once an ingredient is approved as a drug, it cannot also be sold as a dietary supplement or food additive without an exception.
🔮 What’s Coming Next?
There is growing pressure on the FDA to establish clear regulatory guidelines for CBD. As of early 2025:
- Lawmakers are proposing CBD oversight be moved to dietary supplement frameworks
- Bills are being considered to legalize CBD in foods under set dosage limits
- Industry experts expect movement within 1–2 years
✅ Final Thoughts
While CBD is federally legal, its regulatory status is still unsettled. The FDA is playing catch-up, and until clearer rules are established, consumers must rely on transparency and education, and brands must stay compliant to avoid warnings or shutdowns.
At CherryCommission.org, we break down cannabis policy so the public stays informed—not confused.
